ping an-杏耀平台代理注册

font size:
杏耀平台代理注册
online message
contact information
one of telephone, mobile phone number, e-mail is required
contact
tel
mobile phone
email
qq
wechat account
message
other additions
verification code
2022
2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022

our company obtained the national exclusive agency right of dongyingpei indopril tertbutylamine tablets.

recently, our company on hypertension line, preferred drug yitai® perindopril tert-butylamine tablets and shangyao dongying ( jiangsu ) pharmaceutical co., ltd. to reach a strategic cooperation, access to the product exclusive national agency.

more

we have obtained the right to sell fuso teiyaku fever relief patches in some provinces

we have recently entered into a partnership with fuso teikoku qingdao co.,

more
目前在第1页, 共有0页, 共有0条记录 跳转到页
about us
about us development history company honor
business scope
market sales technology development manufacture center
products
antibiotics digestive system medication cardiovascular and cerebrovascular medication bone and muscle medication dermatological medication nervous system medication respiratory system medication others
news release
company news notice
contact us
  • official wechat account official wechat account
  • mobile pagemobile page
  • service tel0755-2552 7000
  • business tel0755-2552 7386
linkssite mapprivacy policy
杏耀平台代理注册 copyright @ 2022 c&o pharmaceutical technology (holdings) limited. all rights reserved.
网站地图